Torrent Pharmaceuticals on Friday said its consolidated profit after tax rose 17 per cent to Rs 453 crore in the September quarter, led by robust sales in the domestic market. The drug firm had reported a Profit After Tax (PAT) of Rs 386 crore in the July-September period of the last fiscal.
| Subscribe To Our Free Newsletter |
